ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Forward Therapeutics at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Forward Therapeutics brings 2 presentations to ACR Convergence 2026 in Orlando. Its program centres on FT2109, an oral TNFR1 signaling inhibitor, covering its preclinical characterization and a first-in-human dose study in healthy participants.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
Forward Therapeutics Boston, MA | |
Clinical-stage biotechnology company developing oral small-molecule therapies for inflammation-driven diseases. | Poster Sun Nov 8 10:30am–12:30pm |
Find decision makers at Forward Therapeutics
Tell us what you sell and we’ll find the people at Forward Therapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction